Frank Mathias will join the executive board of MediGene AG in charge of marketing and business development effective 1 April 2008. Dr Mathias was previously general manager of Amgen GmbH.
In his new role, Dr Mathias will run MediGene’s planned marketing activities including preparing for the launch of a new anti-inflammatory product and a product for genital warts. He will also develop the product portfolio by licensing marketing rights. Dr Mathias has about 20 years of experience marketing drugs at a senior level at Hoechst, Albert-Roussel Pharma, Servier and with Amgen.
MediGene is based in Martinsried/Munich, Germany and is developing treatments for cancer and autoimmune diseases.
Source:
MediGene press release, 21 December 2007
Copyright 2008 Evernow Publishing Ltd